Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Modeling of Surfactant Interaction on Phospholipid Bilayers Mimicking Corneal Epithelium.

Journal of chemical theory and computation·2026
Same author

Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.

Nature communications·2026
Same author

Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung Cancers.

ACS medicinal chemistry letters·2026
Same author

Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author

Unravelling the dynamics of the maturation protein in MS2 bacteriophage via molecular simulations.

Scientific reports·2025
Same author

Accelerating fragment-based drug discovery using grand canonical nonequilibrium candidate Monte Carlo.

Nature communications·2025

Related Experiment Video

Updated: Nov 1, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.7K

Computational Methods and Tools in Antimicrobial Peptide Research.

Pietro G A Aronica1, Lauren M Reid1,2,3, Nirali Desai1,4

  • 1Bioinformatics Institute at A*STAR (Agency for Science, Technology and Research), 30 Biopolis Street, #07-01 Matrix, Singapore 138671.

Journal of Chemical Information and Modeling
|June 24, 2021
PubMed
Summary
This summary is machine-generated.

Antimicrobial peptides (AMPs) offer a promising alternative to antibiotics against resistant bacteria. Molecular modeling, machine learning, and simulations accelerate AMP discovery and development by linking structure, dynamics, and function.

Keywords:
aggregationantibiotic resistanceantimicrobial peptidesartificial intelligencecomputational chemistrymachine learningmembranesmolecular dynamicspeptide engineeringpeptides

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

522
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

522
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.2K

Area of Science:

  • Microbiology
  • Biochemistry
  • Computational Biology

Background:

  • Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) are a promising class of molecules with broad-spectrum activity against various pathogens.
  • Traditional antibiotic development faces challenges due to increasing resistance.

Purpose of the Study:

  • To review the application of molecular modeling techniques in the design and development of antimicrobial peptides (AMPs).
  • To provide researchers with a comprehensive overview of computational tools and resources for AMP research.
  • To highlight the synergy between experimental and computational approaches in advancing AMP-based therapies.

Main Methods:

  • Utilizing molecular models to explore structure-activity relationships of AMPs.
  • Applying machine learning algorithms for predicting AMP efficacy and designing novel peptides.
  • Employing molecular dynamics simulations to understand AMP behavior and mechanisms of action.
  • Compiling databases, web servers, and common techniques for computational AMP research.

Main Results:

  • Molecular modeling provides insights into the complex interplay between AMP structure, dynamics, and antimicrobial function.
  • Machine learning and simulations accelerate the identification and optimization of potent AMP candidates.
  • Computational approaches effectively complement experimental studies, reducing thời gian and cost.
  • A curated list of resources is presented to facilitate researchers' work in the field.

Conclusions:

  • Computational methods, including molecular modeling, machine learning, and simulations, are crucial for advancing antimicrobial peptide research.
  • These tools enable a deeper understanding of AMPs and facilitate the rational design of new therapeutic agents.
  • Integrating computational approaches with experimental validation is key to overcoming the challenge of antibiotic resistance.